Finance

Lists
Q3 2026 earnings • released • EPS met 0,00% • Revenue miss -0,40%
See results
CLN:WSE
Celon Pharma SA
15,44 PLN
-1,28%
(-0,20) 1D
20-ноя., 17:00:00 GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
15,70 PLN
High
15,96 PLN
Low
15,32 PLN
Mkt. cap
832,39 млн
Avg. vol.
31,91 миң
Volume
19,48 миң
P/E ratio
8,05
52-wk high
23,50 PLN
52-wk low
15,20 PLN
EPS
1,92 PLN
Shares outstanding
53,91 млн
No. of employees
572
Open
15,70 PLN
High
15,96 PLN
Low
15,32 PLN
Mkt. cap
832,39 млн
Avg. vol.
31,91 миң
Volume
19,48 миң
P/E ratio
8,05
52-wk high
23,50 PLN
52-wk low
15,20 PLN
EPS
1,92 PLN
Shares outstanding
53,91 млн
No. of employees
572
News stories
From web sources and news partners
About Celon Pharma SA
CEO-
Employees572
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
2026-ж., 18-ноя.
Fiscal period
Q3 2026
0,08 PLN / -
0,00%miss
Revenue / Est. (PLN)
63,25 млн / 63,50 млн
-0,40%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
66,67 млн
65,26 млн
55,57 млн
63,25 млн
Cost of goods sold
11,54 млн
16,70 млн
14,92 млн
16,86 млн
Cost of revenue
11,54 млн
16,70 млн
14,92 млн
16,86 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35,44 млн
36,08 млн
38,62 млн
31,80 млн
Operating expense
52,60 млн
54,54 млн
50,11 млн
48,88 млн
Total operating expenses
64,14 млн
71,23 млн
65,04 млн
65,74 млн
Operating income
2,53 млн
-5,98 млн
-9,46 млн
-2,49 млн
Other non operating income
-250,00 миң
169,05 млн
3,48 млн
179,00 миң
EBT including unusual items
-6,57 млн
160,34 млн
-7,38 млн
-3,50 млн
EBT excluding unusual items
-6,57 млн
160,34 млн
-7,38 млн
-3,50 млн
Income tax expense
18,33 млн
1,70 млн
23,21 млн
-
Effective tax rate
-279,14%
1,06%
-314,48%
-
Other operating expenses
6,37 млн
7,33 млн
1,36 млн
7,26 млн
Net income
-24,90 млн
158,64 млн
-30,59 млн
-3,50 млн
Net profit margin
-37,35%
243,09%
-55,05%
-5,54%
Earnings per share
-
-
-
-
Interest and investment income
149,00 миң
151,00 миң
151,00 миң
-
Interest expense
-341,00 миң
-915,00 миң
-1,55 млн
-1,20 млн
Net interest expenses
-192,00 миң
-764,00 миң
-1,40 млн
-1,20 млн
Depreciation and amortization charges
10,78 млн
11,13 млн
10,13 млн
9,82 млн
EBITDA
11,40 млн
3,44 млн
-748,00 миң
10,47 млн
Gain or loss from assets sale
-2,91 млн
-569,00 миң
716,00 миң
6,88 млн
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору